There are 2789 resources available
729P - Adoptive T-cell therapy during chemotherapy with or without peginterferon-α (IFNα) in patients with platinum sensitive recurrent epithelial ovarian cancer (EOC)
Presenter: Judith Kroep
Session: ePoster Display
730P - Anlotinib in patients with recurrent platinum-resistant or -refractory ovarian carcinoma: A prospective, single-arm, single-center, phase II clinical study
Presenter: Huaying Wang
Session: ePoster Display
731P - Multi-maintenance olaparib in relapsed, platinum-sensitive BRCA-mutant high-grade serous ovarian carcinoma (MOLTO): A phase II feasibility study
Presenter: Robert Morgan
Session: ePoster Display
732P - Anlotinib plus pemetrexed in patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study
Presenter: Jueming Chen
Session: ePoster Display
910P - Repurposing pantoprazole in advanced head and neck squamous cell carcinoma: A phase I/II randomized study
Presenter: Vanita Noronha
Session: ePoster Display
912P - Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
Presenter: Viktor Gruenwald
Session: ePoster Display
913P - Apatinib for heavily pretreated recurrent and/or metastatic head and neck squamous cell carcinoma: Updated analysis
Presenter: kunyu yang
Session: ePoster Display
914P - Impact of induction chemotherapy (ICT) in borderline resectable or unresectable locally advanced oral squamous cell carcinoma (OSCC)
Presenter: Divya Kukreja
Session: ePoster Display
915P - Carboplatin in combination with three weekly paclitaxel as first line therapy in patients with recurrent/metastatic head and neck cancers: A regional cancer center experience
Presenter: Pooja Babbar
Session: ePoster Display